Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

The National Conference of State Legislatures is urging Congress to pass its Secure and Fair Enforcement Regulation (SAFER) Banking Act. Passage of SAFER would permit banks to offer ordinary banking services to legal marijuana businesses -- services they lack access to today.

Why Canopy Growth Stock Is Glowing Green Today

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Cannabis stocks to buy now could see higher highs, as we near the U.S. elections.  For one, a growing number of Americans want to see legalization.

The 3 Best Cannabis Stocks to Buy Now: Q2 Edition

Curaleaf Holdings, Inc.

Tilray Brands

Tilray Brands and Canopy Growth are often the default options for investors looking for cannabis stocks. But those are risky, cash-burning businesses counting on the hopes that the U.S. legalizes marijuana soon.

The Best Cannabis Stock to Invest $1,000 in Right Now

Aurora Cannabis

Cronos Group

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF 

With April 20 approaching (a notable cannabis celebration indeed), thoughts may turn to investing in marijuana stocks. However, beyond the symbolic date, imminent catalysts could drive significant growth in this sector for speculators and those wishing well on the providers of sticky icky turning higher.

High Hopes: Could 4/20 Light Up a Cannabis Stock Rally?

As we move into mid-April 2024, Canadian marijuana stocks are capturing the attention of investors, given the ongoing developments and shifts in the global cannabis market. Stocks like Tilray, Canopy Growth, and Aurora Cannabis are notable for their robust international operations and diverse product lines. Tilray, for example, has expanded its presence in the U.S. through acquisitions like MedMan, positioning it well to capitalize on potential market expansions. Canopy Growth has made significant strides in operational efficiency, achieving considerable cost savings and enhancing its financial health, which speaks to its ability to navigate a complex market landscape.

April 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now

Despite a seemingly positive move forward, Canopy Growth (NASDAQ: CGC ) shares are experiencing significant volatility today. Part of that may stem from dilution risks tied to its business decision, which involves creating a separate U.S.-focused enterprise.

CGC Stock Alert: Canopy Growth Gets Green Light for Canopy USA

Canopy Growth shrank significantly over the last few years. Management has its fingers crossed for marijuana legalization in the U.S. Even that might not be enough to make it an appealing investment.

Canopy Growth: Buy, Sell, or Hold?

Shareholders overwhelmingly approve the creation of a new class of Exchangeable Shares of Canopy Growth, enabling the acceleration of Canopy Growth's entry into the U.S. THC market, which is expected to be approximately $50B in 2026.1 Canopy USA expected to advance imminently with triggering acquisition of U.S. assets. SMITHS FALLS, ON, April 15, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced the voting results from its special meeting of shareholders held on Friday, April 12, 2024 (the "Meeting").

CANOPY GROWTH ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS

Despite a volatile week for cannabis specialist Canopy Growth (NASDAQ: CGC ), CGC stock has enjoyed a tremendous performance over the past month, gaining about 163%. Currently, shareholders are voting on two proposals related to the creation of a U.S.-based entity called Canopy USA.

CGC Stock Is on Watch Amid ‘Canopy USA' Vote

Village Farms International

Marijuana stock investors are seeing the future of cannabis and investing transforming. What does this mean exactly? So from earlier on in the green rush most marijuana stocks traded as if they were never coming down. The excitement of publicly traded cannabis companies being traded on the open market was incredible. Even when slight drops would occur they were often followed by strong recoveries. Now this was back in 2018, and 2019.

These Marijuana Stocks Could Begin To Rise Again?

Canopy Growth is eager to enter the U.S. cannabis market. If legalization takes place within the next decade, it could be off to the races for the cannabis producer.

Where Will Canopy Growth Be in 10 Years?

Tilray reported weaker-than-expected sales growth and a big GAAP loss this morning. Competing marijuana stocks are suffering, too.

Why Marijuana Stocks Got Burnt Today

It has been a great month for Canopy Growth (NASDAQ: CGC ), as shares of CGC stock are up by more than 230%. These gains have been led by a combination of several factors, such as comments from President Joe Biden and Vice President Kamala Harris about reclassifying marijuana from a Schedule 1 drug, the legalization of marijuana in Germany and a November vote to legalize recreational marijuana in Florida.

CGC Stock: What to Know Ahead of Canopy Growth's Share Conversion Vote This Week

Sen. Chuck Schumer expects to see the SAFER marijuana banking reform get taken up by the full Senate in the next few months. Passage of the law would allow marijuana companies to use standard banking services, which would lower their costs and raise their profits.

Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday

Cannabis stocks have been on an absolute tear, and Canopy Growth (NASDAQ: CGC ) is no exception. Shares of CGC stock are up by over 250% during the past month.

The 5 Biggest Buyers of Canopy Growth (CGC) Stock

SNDL Inc.

Cannabis stocks are continuing to rise on good news about legalization. Over the last month, Canopy Growth (NYSE: CGC ) is up 239%, Aurora Cannabis (NYSE: ACB ) is up 127%, SNDL (NASDAQ: SNDL ) is up 81%, Tilray Brands (NASDAQ: TLRY ) is up 68%, and Cronos Group (NASDAQ: CRON ) is up 42%.

Cannabis Stocks Alert: 3 Big Reasons TLRY, ACB, CGC and SNDL Keep Gaining

Archer Aviation

Kinross Gold

Lithium Americas Corp

Nordic American Tankers

Ring Energy

For small investors, low-price stocks are a good option to create a diversified portfolio. Of course, most of these stocks represent emerging companies and overall portfolio exposure should be limited.

7 Under-$10 Stocks to Buy for 5-Bagger Returns in 5 Years

From last summer's low, the Pure US Cannabis ETF has doubled, to a recent $10.25.

Weed Stocks Are in the Green Again

A one-time Canopy Growth executive is taking the helm of a Canadian cannabis industry lobbying group. Concurrently, the No.

Why Canadian Marijuana Stocks Popped Today

Cannabis stocks are on the move Tuesday after the Florida Supreme Court approved the ability to add recreational marijuana use to the state's November ballot. This measure will have residents of Florida voting for or against a new amendment that would allow the use of the drug.

Cannabis Stocks Light Up As Florida Adds Weed to November Ballots

Cannabis stocks often rally on news of any renewed hopes of legalization passing. Many cannabis producers aren't in great financial shape, however.

This Is the Biggest Mistake I See Cannabis Investors Making Over and Over Again

Various themes and sectors garnered buzz and attention as the first quarter drew to a close. However, one industry that has been in a lull for a significant period reignited the imagination and hope of longstanding investors after it finished the first quarter in style.

Green Gold Rush: Here's What's Driving Cannabis Stocks Higher

Canopy Growth (NASDAQ: CGC ) stock is in the red today but still up more than 130% during the past month. This morning, the cannabis company filed a new press release concerning its upcoming special meeting of stockholders on April 12.

Dear CGC Stock Fans, Mark Your Calendars for April 12

Canopy Growth Corp.'s stock fell Monday from recent gains after Institutional Shareholder Services recommended shareholders of the cannabis company approve a measure that would clear the way for the creation of Canopy USA LLC.

Canopy Growth wins ISS support for vote to pave way for entry into U.S. cannabis market

Cannabis stocks are on the move Monday as investors react to the news that recreational marijuana is now legal in Germany. These new laws do come with some restrictions worth pointing out.

News for Canopy Growth Stock (CGC)